Roth Capital initiated coverage on shares of The Joint Corp. (NASDAQ:JYNT) in a report issued on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $5.70 price target on the stock.

A number of other analysts have also weighed in on JYNT. ValuEngine raised shares of The Joint Corp. from a sell rating to a hold rating in a research note on Tuesday, June 6th. Zacks Investment Research lowered shares of The Joint Corp. from a hold rating to a sell rating in a research note on Tuesday, April 4th. Finally, Craig Hallum initiated coverage on shares of The Joint Corp. in a research note on Wednesday, June 14th. They set a buy rating and a $5.75 target price for the company. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and an average price target of $5.61.

The Joint Corp. (JYNT) traded down 2.08% during midday trading on Thursday, hitting $3.76. 3,812 shares of the stock were exchanged. The Joint Corp. has a 52 week low of $1.96 and a 52 week high of $4.74. The stock’s market cap is $49.19 million. The firm’s 50-day moving average is $3.71 and its 200 day moving average is $3.82.

ILLEGAL ACTIVITY NOTICE: “The Joint Corp. (JYNT) Coverage Initiated at Roth Capital” was published by Watch List News and is the property of of Watch List News. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.watchlistnews.com/the-joint-corp-jynt-coverage-initiated-at-roth-capital/1464253.html.

In related news, Director James H. Amos, Jr. acquired 10,000 shares of the company’s stock in a transaction on Friday, June 30th. The shares were purchased at an average price of $3.85 per share, for a total transaction of $38,500.00. Following the purchase, the director now owns 57,295 shares in the company, valued at $220,585.75. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO John P. Meloun acquired 6,850 shares of the company’s stock in a transaction on Tuesday, June 27th. The stock was bought at an average price of $3.69 per share, for a total transaction of $25,276.50. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 20,670 shares of company stock valued at $78,140. 6.10% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in JYNT. Sanders Morris Harris LLC raised its position in The Joint Corp. by 0.5% in the second quarter. Sanders Morris Harris LLC now owns 2,619,807 shares of the company’s stock valued at $9,955,000 after buying an additional 12,000 shares in the last quarter. Sanders Morris Harris Inc. raised its position in The Joint Corp. by 0.3% in the first quarter. Sanders Morris Harris Inc. now owns 2,607,807 shares of the company’s stock valued at $10,952,000 after buying an additional 7,200 shares in the last quarter. Skylands Capital LLC raised its position in The Joint Corp. by 4.1% in the first quarter. Skylands Capital LLC now owns 565,229 shares of the company’s stock valued at $2,374,000 after buying an additional 22,500 shares in the last quarter. Russell Investments Group Ltd. raised its position in The Joint Corp. by 24.9% in the second quarter. Russell Investments Group Ltd. now owns 87,900 shares of the company’s stock valued at $334,000 after buying an additional 17,500 shares in the last quarter. Finally, Pekin Singer Strauss Asset Management IL raised its position in The Joint Corp. by 29.4% in the first quarter. Pekin Singer Strauss Asset Management IL now owns 71,669 shares of the company’s stock valued at $301,000 after buying an additional 16,292 shares in the last quarter. Hedge funds and other institutional investors own 45.91% of the company’s stock.

About The Joint Corp.

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Receive News & Ratings for The Joint Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Joint Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.